Intrinsic Value of S&P & Nasdaq Contact Us

Cybin Inc. CYBN NYSE

NYSE • Healthcare • Biotechnology • CA • USD

SharesGrow Score
49/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — CYBN

Cybin Inc. (CYBN) has a market capitalization of $413.02M and trades at $8.28. The 52-week range is 4.81-10.7199.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -13.6, Earnings Per Share (EPS) of $-0.61.

The stock has a beta of 0.79, operates in the Healthcare sector.

Trading Data
Current Price$8.28
52-Week Range4.81-10.7199
Volume716.53K
Avg Volume (30D)874.38K
Market Cap$413.02M
Beta (1Y)0.79
Company
IPO Date2019-09-13
Employees50
CEOEric So
CountryCA
ExchangeNYSE
CurrencyUSD
ISINCA23256X4075
CUSIP23256X407
Income (Latest Year)
EBITDA$-142.67M
Operating Income$-143.15M
Net Income$-113.14M
EPS$-0.61
EPS Diluted$-0.61
Shares Outstanding$185.43M
Balance Sheet (Latest Year)
Total Assets$258.62M
Current Assets$165.97M
Cash & ST Investments$135.02M
Total Liabilities$21.42M
Net Debt$-135.02M
Total Equity$237.2M
Valuation Ratios
P/E Ratio-13.6
P/B Ratio1.74
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message